Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RACHEL LINER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1952878340
CMS profile
5696189
Location
MONTGOMERY, AL

General Payments · PY2019–2024

$2,127.07

  • Reported across 136 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$620.04

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $620.04 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $196.23 17
Takeda Pharmaceuticals U.S.A., Inc. $120.12 5
Otsuka America Pharmaceutical, Inc. $99.49 5
Lundbeck LLC $87.53 3
Alkermes, Inc. $60.82 3
Axsome Therapeutics, Inc. $55.85 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $39.31 2
PY2021 $265.79 21
PY2022 $489.99 33
PY2023 $711.94 44
PY2024 $620.04 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $5.10 01/17/2024 Food and Beverage Undisputed 01/23/2026 1107542211 CMS
ABBVIE INC. $5.32 01/30/2024 Food and Beverage Undisputed 01/23/2026 1107542213 CMS
ABBVIE INC. $9.37 02/26/2024 Food and Beverage Undisputed 01/23/2026 1107542215 CMS
ABBVIE INC. $7.83 03/11/2024 Food and Beverage Undisputed 01/23/2026 1107542217 CMS
ABBVIE INC. $5.53 04/10/2024 Food and Beverage Undisputed 01/23/2026 1107542219 CMS
ABBVIE INC. $12.11 04/24/2024 Food and Beverage Undisputed 01/23/2026 1107542221 CMS
ABBVIE INC. $19.07 05/14/2024 Food and Beverage Undisputed 01/23/2026 1107542223 CMS
ABBVIE INC. $12.42 05/22/2024 Food and Beverage Undisputed 01/23/2026 1107542225 CMS
ABBVIE INC. $13.99 06/18/2024 Food and Beverage Undisputed 01/23/2026 1107542227 CMS
ABBVIE INC. $16.38 07/10/2024 Food and Beverage Undisputed 01/23/2026 1107542229 CMS
ABBVIE INC. $13.38 08/27/2024 Food and Beverage Undisputed 01/23/2026 1107542231 CMS
ABBVIE INC. $18.20 09/04/2024 Food and Beverage Undisputed 01/23/2026 1107542233 CMS
ABBVIE INC. $12.31 09/24/2024 Food and Beverage Undisputed 01/23/2026 1107542235 CMS
ABBVIE INC. $18.14 10/01/2024 Food and Beverage Undisputed 01/23/2026 1107542237 CMS
ABBVIE INC. $6.47 10/08/2024 Food and Beverage Undisputed 01/23/2026 1107542239 CMS
ABBVIE INC. $9.69 11/06/2024 Food and Beverage Undisputed 01/23/2026 1107542241 CMS
ABBVIE INC. $10.92 11/12/2024 Food and Beverage Undisputed 01/23/2026 1107542243 CMS
Alkermes, Inc. $20.56 01/10/2024 Food and Beverage Undisputed 01/23/2026 1120542585 CMS
Alkermes, Inc. $19.56 02/06/2024 Food and Beverage Undisputed 01/23/2026 1120542587 CMS
Alkermes, Inc. $20.70 10/12/2024 Food and Beverage Undisputed 01/23/2026 1120542589 CMS
Axsome Therapeutics, Inc. $16.66 02/20/2024 Food and Beverage Undisputed 01/23/2026 1148401035 CMS
Axsome Therapeutics, Inc. $16.78 04/04/2024 Food and Beverage Undisputed 01/23/2026 1148401037 CMS
Axsome Therapeutics, Inc. $22.41 05/13/2024 Food and Beverage Undisputed 01/23/2026 1148401039 CMS
Lundbeck LLC $28.02 01/29/2024 Food and Beverage Undisputed 01/23/2026 1146051957 CMS
Lundbeck LLC $31.59 02/14/2024 Food and Beverage Undisputed 01/23/2026 1146051959 CMS
Lundbeck LLC $27.92 04/08/2024 Food and Beverage Undisputed 01/23/2026 1146051961 CMS
Otsuka America Pharmaceutical, Inc. $14.10 02/07/2024 Food and Beverage Undisputed 01/23/2026 1119123238 CMS
Otsuka America Pharmaceutical, Inc. $23.07 03/13/2024 Food and Beverage Undisputed 01/23/2026 1119123240 CMS
Otsuka America Pharmaceutical, Inc. $23.98 03/14/2024 Food and Beverage Undisputed 01/23/2026 1119123242 CMS
Otsuka America Pharmaceutical, Inc. $16.58 07/11/2024 Food and Beverage Undisputed 01/23/2026 1119123244 CMS
Otsuka America Pharmaceutical, Inc. $21.76 08/21/2024 Food and Beverage Undisputed 01/23/2026 1119123246 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.97 01/04/2024 Food and Beverage Undisputed 01/23/2026 1137782096 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.52 02/14/2024 Food and Beverage Undisputed 01/23/2026 1137782098 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.70 02/22/2024 Food and Beverage Undisputed 01/23/2026 1137782100 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.86 06/26/2024 Food and Beverage Undisputed 01/23/2026 1137782102 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.07 08/12/2024 Food and Beverage Undisputed 01/23/2026 1137782104 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.